Consensus Nicox SA Börse Stuttgart

Stocks

NXOA

FR0013018124

Pharmaceuticals

Market Closed - Börse Stuttgart 23:56:12 18/09/2026 +04			5-day change	1st Jan Change
0.3160 ^EUR	+0.80%		+24.41%	+14.49%

09-16	Nicox to present NCX 470 data at a conference
09-11	Chinese Regulator Accepts Nicox's Glaucoma Drug Application for Review	MT

Evolution of the Average Target: Nicox SA

Data source: Nicox SA(ALCOX)

Evolution of the Target Price: Nicox SA

Data source: Nicox SA(ALCOX)

Changes in Analyst Recommendations: Nicox SA

Data source: Nicox SA(ALCOX)

40b856ec06d25a6b5c422b836f44600b._xS5Emy3VGCWr7aanyy_DaUDQPtux7dBG11_4AZN06E.ikDXfC7FIhfg5O7C7nWIasw7E5gFn_84dGQojUA06pW3J9ZVKPQOKtvq9w~819bd49d4cadbefd5e5704f473c6dc8f

Specialty & Advanced Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	MERCK & CO., INC.					+4.15%
	MERCK KGAA					+18.76%
	HALOZYME THERAPEUTICS, INC.					-11.47%
	KYOWA KIRIN CO., LTD.					+1.14%
	SK BIOPHARMACEUTICALS CO., LTD.					+68.81%
	YUHAN CORPORATION					+50.9%
	BETTA PHARMACEUTICALS CO., LTD.			-	-	-14.97%
	SUPERNUS PHARMACEUTICALS, INC.					+47.02%
	Average					+20.54%
	Weighted average by Cap.					+6.85%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

0.3360EUR

Average target price

1.000EUR

Spread / Average Target

+197.62%

High Price Target

1.000EUR

Spread / Highest target

+197.62%

Low Price Target

1.000EUR

Spread / Lowest Target

+197.62%

Analyst Consensus Detail

Consensus revision (last 18 months)

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!